Browse > Article
http://dx.doi.org/10.3348/kjr.2018.19.2.352

Incidence of Breakthrough Reaction in Patients with Prior Acute Allergic-Like Reactions to Iodinated Contrast Media according to the Administration Route  

Kim, Yeon Soo (Department of Radiology, Seoul National University College of Medicine, Seoul National University Hospital)
Choi, Young Hun (Department of Radiology, Seoul National University College of Medicine, Seoul National University Hospital)
Cho, Yeon Jin (Department of Radiology, Seoul National University College of Medicine, Seoul National University Hospital)
Lee, Seunghyun (Department of Radiology, Seoul National University College of Medicine, Seoul National University Hospital)
Yoon, Soon Ho (Department of Radiology, Seoul National University College of Medicine, Seoul National University Hospital)
Park, Chang Min (Department of Radiology, Seoul National University College of Medicine, Seoul National University Hospital)
Kang, Hye Ryun (Department of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine)
Publication Information
Korean Journal of Radiology / v.19, no.2, 2018 , pp. 352-357 More about this Journal
Abstract
Objective: This study assessed the risk of acute allergic-like reactions (AARs) after extravascular administration of iodinated contrast media (ICM) in at-risk patients compared with that after intravascular ICM administration. Materials and Methods: From July 2012 to January 2016, 264 patients with a history of moderate or severe reactions to ICM, with re-exposure to ICM intravascularly or extravascularly were included. The incidence of recurrent AARs after ICM re-exposure were assessed according to the administration routes by reviewing electronic medical records and comparison between the two routes. Results: Among 264 patients, 244 patients had been subsequently exposed to ICM intravascularly, 7 patients via an extravascular route and 13 patients with dual re-exposure. Of 257 patients with intravascular ICM re-exposure, 87 (33.9%) had mild to severe recurrent AARs and 143 (19.5%) cases of recurrent AARs occurred among 733 cases of intravascular ICM re-exposure on a case-by-case basis. However, there was no case of recurrent ARR after extravascular administration of ICM in 20 patients (45 cases) with ICM administrated extravascularly. Conclusion: For high-risk patients with a history of moderate or severe reactions to ICM, AARs upon extravascular administration of ICM are significantly infrequent compared with intravascular ICM administration.
Keywords
Anaphylaxis; Risk; Premedication;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 2003;76:513-518   DOI
2 Hunt CH, Hartman RP, Hesley GK. Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses. AJR Am J Roentgenol 2009;193:1124-1127   DOI
3 ACR Committee on Drugs and Contrast Media. ACR manual on contrast media. Ver 10.2. American College of Radiology, 2016
4 Cochran ST, Bomyea K, Sayre JW. Trends in adverse events after IV administration of contrast media. AJR Am J Roentgenol 2001;176:1385-1388   DOI
5 Brockow K, Christiansen C, Kanny G, Clement O, Barbaud A, Bircher A, et al.; ENDA; EAACI Interest Group on Drug Hypersensitivity. Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005;60:150-158   DOI
6 Park EA, Lee W, Kang DK, Kim SJ, Kim YJ, Kim Y, et al. Comparison of iohexol-380 and iohexol-350 for coronary CT angiography: a multicenter, randomized, double-blind phase 3 trial. Korean J Radiol 2016;17:330-338   DOI
7 Morcos SK. Acute serious and fatal reactions to contrast media: our current understanding. Br J Radiol 2005;78:686-693   DOI
8 Tramèr MR, von Elm E, Loubeyre P, Hauser C. Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. BMJ 2006;333:675   DOI
9 Lee SY, Yang MS, Choi YH, Park CM, Park HW, Cho SH, et al. Stratified premedication strategy for the prevention of contrast media hypersensitivity in high-risk patients. Ann Allergy Asthma Immunol 2017;118:339-344.e1   DOI
10 Yoon SH, Lee SY, Kang HR, Kim JY, Hahn S, Park CM, et al. Skin tests in patients with hypersensitivity reaction to iodinated contrast media: a meta-analysis. Allergy 2015;70:625-637   DOI
11 Miller SH. Anaphylactoid reaction after oral administration of diatrizoate meglumine and diatrizoate sodium solution. AJR Am J Roentgenol 1997;168:959-961   DOI
12 Gmeinwieser J, Erhardt W, Reimann HJ, Babic R, Speck U, Wenzel-Hora B. Side effects of water-soluble contrast agents in upper gastrointestinal tract. Invest Radiol 1990;25 Suppl 1:S27-S28   DOI
13 Pan JJ, Draganov PV. Adverse reactions to iodinated contrast media administered at the time of endoscopic retrograde cholangiopancreatography (ERCP). Inflamm Allergy Drug Targets 2009;8:17-20   DOI
14 Draganov P, Cotton PB. Iodinated contrast sensitivity in ERCP. Am J Gastroenterol 2000;95:1398-1401   DOI
15 Skucas J. Anaphylactoid reactions with gastrointestinal contrast media. AJR Am J Roentgenol 1997;168:962-964   DOI
16 Witten DM, Hirsch FD, Hartman GW. Acute reactions to urographic contrast medium: incidence, clinical characteristics and relationship to history of hypersensitivity states. Am J Roentgenol Radium Ther Nucl Med 1973;119:832-840   DOI
17 Pirmohamed M, Naisbitt DJ, Gordon F, Park BK. The danger hypothesis--potential role in idiosyncratic drug reactions. Toxicology 2002;181-182:55-63   DOI
18 Mann K, Rendl J, Busley R, Saller B, Seybold S, Hoermann R, et al. Systemic iodine absorption during endoscopic application of radiographic contrast agents for endoscopic retrograde cholangiopancreaticography. Eur J Endocrinol 1994;130:498-501   DOI
19 Davis PL. Anaphylactoid reactions to the nonvascular administration of water-soluble iodinated contrast media. AJR Am J Roentgenol 2015;204:1140-1145   DOI
20 Park HJ, Park JW, Yang MS, Kim MY, Kim SH, Jang GC, et al. Re-exposure to low osmolar iodinated contrast media in patients with prior moderate-to-severe hypersensitivity reactions: a multicentre retrospective cohort study. Eur Radiol 2017;27:2886-2893   DOI
21 Davenport MS, Cohan RH, Caoili EM, Ellis JH. Repeat contrast medium reactions in premedicated patients: frequency and severity. Radiology 2009;253:372-379   DOI
22 Shehadi WH. Contrast media adverse reactions: occurrence, recurrence, and distribution patterns. Radiology 1982;143:11-17   DOI
23 Freed KS, Leder RA, Alexander C, DeLong DM, Kliewer MA. Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication. AJR Am J Roentgenol 2001;176:1389-1392   DOI
24 Wolf GL, Mishkin MM, Roux SG, Halpern EF, Gottlieb J, Zimmerman J, et al. Comparison of the rates of adverse drug reactions. Ionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26:404-410   DOI
25 Brockow K, Romano A, Aberer W, Bircher AJ, Barbaud A, Bonadonna P, et al.; European Network of Drug Allergy and the EAACI Interest Group on Drug Hypersensitivity. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy 2009;64:234-241   DOI
26 Sancak S, Jaeschke H, Eren F, Tarcin O, Guellueoglu B, Sen LS, et al. High prevalence of $TSHR/Gs{\alpha} $mutation-negative clonal hot thyroid nodules (HNs) in a Turkish cohort. Horm Metab Res 2011;43:562-568   DOI
27 Lasser EC, Berry CC, Mishkin MM, Williamson B, Zheutlin N, Silverman JM. Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media. AJR Am J Roentgenol 1994;162:523-526   DOI